{"created":"2023-04-21T01:55:37.335557+00:00","id":2005708,"links":{},"metadata":{"_buckets":{"deposit":"bd991da0-9771-4c58-8a7a-3778623f62dd"},"_deposit":{"created_by":17,"id":"2005708","owners":[17],"pid":{"revision_id":0,"type":"depid","value":"2005708"},"status":"published"},"_oai":{"id":"oai:nagoya.repo.nii.ac.jp:02005708","sets":["499:960:1165"]},"author_link":[],"control_number":"2005708","item_1619764877189":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士(医学)","subitem_degreename_language":"ja"}]},"item_1619764903829":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"名古屋大学"},{"subitem_degreegrantor_language":"en","subitem_degreegrantor_name":"Nagoya University"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"13901","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_1619764932197":{"attribute_name":"学位授与年度","attribute_value_mlt":[{"subitem_text_value":"2022"}]},"item_1619764970493":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2023-03-27"}]},"item_1619765001901":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第14460号"}]},"item_9_alternative_title_19":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"治療抵抗性の加齢黄斑変性症例に対するafliberceptからbrolucizumabへの切り替え","subitem_alternative_title_language":"ja"}]},"item_9_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2023-03-27","bibliographicIssueDateType":"Issued"}}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"太田, 光","creatorNameLang":"ja"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-07-31"}],"displaytype":"detail","filename":"k14460_abstract.pdf","filesize":[{"value":"1.4 MB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"objectType":"abstract","url":"https://nagoya.repo.nii.ac.jp/record/2005708/files/k14460_abstract.pdf"},"version_id":"9d9980b7-0db7-469c-acd8-80aead42ffc7"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-07-31"}],"displaytype":"detail","filename":"k14460_publication_list.pdf","filesize":[{"value":"108 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"objectType":"other","url":"https://nagoya.repo.nii.ac.jp/record/2005708/files/k14460_publication_list.pdf"},"version_id":"fe2528f4-7143-4e5b-9c50-e1488a1a3ebf"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-07-31"}],"displaytype":"detail","filename":"k14460_review.pdf","filesize":[{"value":"729 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"objectType":"other","url":"https://nagoya.repo.nii.ac.jp/record/2005708/files/k14460_review.pdf"},"version_id":"bdab310c-6c6b-49b2-bfc9-de0e997e5f68"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-07-31"}],"displaytype":"detail","filename":"k14460_summary.pdf","filesize":[{"value":"1.4 MB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"objectType":"summary","url":"https://nagoya.repo.nii.ac.jp/record/2005708/files/k14460_summary.pdf"},"version_id":"698bf3dd-ff86-4e01-8fa2-f91bc2fa69f4"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration","subitem_title_language":"en"}]},"item_type_id":"40001","owner":"17","path":["1165"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-07-31"},"publish_date":"2023-07-31","publish_status":"0","recid":"2005708","relation_version_is_last":true,"title":["Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration"],"weko_creator_id":"17","weko_shared_id":-1},"updated":"2023-07-31T05:18:40.155167+00:00"}